PTEN Protein Loss by IHC Is an Adverse Prognostic Indicator in a High Risk Surgical Cohort of Prostate Cancer Patients

被引：0
|
作者：
Lotan, T. L. [1 ]
Suteliffe, S. [1 ]
Gurel, B. [1 ]
Park, B. H. [1 ]
Humphries, E. [1 ]
Partin, A. W. [1 ]
Han, M. [1 ]
Walsh, P. C. [1 ]
De Marzo, A. M. [1 ]
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
909
引用
收藏
页码：205A / 205A
页数：1
相关论文
共 50 条
  • [41] Prognostic value of p16, PTEN, E-cadherin, and bcl-2 expression in high risk prostate cancer of Korean patients
    Kim, M. J.
    Kim, J. M.
    Sung, W. J.
    Seok, S. H.
    Kim, A. R.
    Im, W. S.
    Park, D. C.
    MODERN PATHOLOGY, 2008, 21 : 163A - 163A
  • [42] Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification
    Bismar, Tarek A.
    Hegazy, Samar
    Feng, Zhaoyong
    Yu, Darryl
    Donnelly, Bryan
    Palanisamy, Nallasivam
    Trock, Bruce J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (11) : 2117 - 2125
  • [43] IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN AS A PROGNOSTIC INDICATOR IN PROSTATE-CANCER
    SHURBAJI, MS
    KALBFLEISCH, JH
    THURMOND, TS
    HUMAN PATHOLOGY, 1995, 26 (01) : 106 - 109
  • [44] Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification
    Tarek A. Bismar
    Samar Hegazy
    Zhaoyong Feng
    Darryl Yu
    Bryan Donnelly
    Nallasivam Palanisamy
    Bruce J. Trock
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2117 - 2125
  • [45] The association of PTEN loss on outcome in patients with early high-risk prostate cancer (CaP) treated with adjuvant docetaxel following radical prostatectomy (RP).
    Keizman, D.
    Zhang, Z.
    Sinibaldi, V. J.
    DeMarzo, A.
    Gurel, B.
    Lotan, T.
    Hicks, J.
    Rosenbaum, E.
    Antonarakis, E. S.
    Kim, J. J.
    Carducci, M. A.
    Eisenberger, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer
    Cremers, Ruben G.
    Aben, Katja K.
    Vermeulen, Sita H.
    den Heijer, Martin
    van Oort, Inge M.
    Kiemeney, Lambertus A.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (18) : 3294 - 3299
  • [47] Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study
    Xu, Xing
    Kharazmi, Elham
    Tian, Yu
    Mukama, Trasias
    Sundquist, Kristina
    Sundquist, Jan
    Brenner, Hermann
    Fallah, Mahdi
    PLOS MEDICINE, 2021, 18 (06)
  • [48] SURGICAL OUTCOMES IN THE MANAGEMENT OF HIGH RISK PROSTATE CANCER USING THE SURGICAL OUTCOMES FOR ADVANCED PROSTATE CANCER SCORE
    Francis, John
    Kim, Simon
    Zhu, Hui
    Abouassaly, Robert
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1310 - E1311
  • [49] PROGNOSTIC ROLE OF MICRORNA 221 IN HIGH RISK PROSTATE CANCER
    Gontero, Paolo
    Zitella, Andrea
    Burkhard, Kneitz
    Pacchioni, Donatella
    Giona, Simone
    Peraldo, Francesca
    Briganti, Alberto
    Steven, Joniau
    Jeffrey, Karnes
    Spahn, Martin
    JOURNAL OF UROLOGY, 2013, 189 (04): : E328 - E329
  • [50] Association of PTEN protein loss with upgrading of prostate cancer from biopsy to radical prostatectomy.
    Carvalho, Filipe L. F.
    Lotan, Tamara L.
    Peskoe, Sarah B.
    Hicks, Jessica
    Good, Jennifer
    Fedor, Helen L.
    Humphreys, Elizabeth B.
    Han, Misop
    Platz, Elizabeth
    Squire, Jeremy
    DeMarzo, Angelo
    Berman, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
12345